| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 32.64B | 32.70B | 32.86B | 33.10B | 32.36B | 24.44B |
| Gross Profit | 5.61B | 5.45B | 5.32B | 4.42B | 5.88B | 4.56B |
| EBITDA | 1.60B | 1.56B | 1.31B | 532.00M | 1.97B | 1.35B |
| Net Income | 548.00M | 522.00M | 220.00M | -444.00M | 811.00M | 501.00M |
Balance Sheet | ||||||
| Total Assets | 37.81B | 37.52B | 40.11B | 38.55B | 40.09B | 35.89B |
| Cash, Cash Equivalents and Short-Term Investments | 3.05B | 2.94B | 3.82B | 2.96B | 3.50B | 3.15B |
| Total Debt | 6.17B | 7.13B | 7.58B | 10.16B | 9.96B | 8.91B |
| Total Liabilities | 18.07B | 18.52B | 21.64B | 21.60B | 23.09B | 19.67B |
| Stockholders Equity | 18.54B | 17.79B | 17.29B | 15.86B | 15.94B | 15.21B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -889.00M | 2.80B | -593.00M | -705.00M | -680.00M |
| Operating Cash Flow | 0.00 | -224.00M | 3.58B | 104.00M | 1.08B | 1.25B |
| Investing Cash Flow | 0.00 | -174.00M | -60.00M | -659.00M | -1.60B | -1.71B |
| Financing Cash Flow | 0.00 | -513.00M | -2.60B | -3.00M | 861.00M | 519.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥35.90B | 9.56 | ― | 1.90% | 2.15% | 16.14% | |
76 Outperform | ¥88.01B | 6.04 | ― | 3.04% | 1.57% | -33.97% | |
76 Outperform | ¥89.98B | 7.61 | ― | 3.02% | 1.66% | 11.28% | |
74 Outperform | ¥40.12B | 15.61 | ― | 3.70% | 14.83% | 51.42% | |
62 Neutral | ¥26.88B | 9.97 | ― | 4.27% | 5.72% | 28.92% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
61 Neutral | ¥8.20B | 22.69 | ― | 1.35% | -2.76% | -25.24% |